This is the authors' abstract. We don't add key points for this paper.
Background: Multiple myeloma is a multifocal hematological disorder, which shows a proliferation of malignant plasma cells in the bone marrow, it represents approximately 1% of all malignancy, causing about 20% of deaths from hematological malignancies. Cyclin D1 is considered an important factor in the cell cycle control; dysregulation of cyclin D1 has an oncogenic role in multiple myeloma patients and can affect their prognosis
No takes yet. Share an insight, caveat, or question.
Abobakr et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: